Document Detail


Dermatomyositis developing in the first trimester of pregnancy.
MedLine Citation:
PMID:  14619391     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Dermatomyositis in pregnancy is rare. Pregnancy may be a precipitating factor at the onset or may develop during the course of dermatomyositis, which would exacerbate disease activity. In this study, we report a 22-year-old female patient who developed generalized skin rash and progressive muscle weakness in the twelfth week of pregnancy. She was diagnosed with dermatomyositis and underwent therapeutic abortion, due to the high fetal mortality rate of the disease when developed in the first trimester. Her symptoms improved with treatment of intravenous immunoglobulin and a high dose of corticosteroids.
Authors:
In Whee Park; Yu Jin Suh; Jae Ho Han; Yoo Seob Shin; Jeong Hee Choi; Hae Sim Park; Chang Hee Suh
Publication Detail:
Type:  Case Reports; Journal Article    
Journal Detail:
Title:  The Korean journal of internal medicine     Volume:  18     ISSN:  1226-3303     ISO Abbreviation:  Korean J. Intern. Med.     Publication Date:  2003 Sep 
Date Detail:
Created Date:  2003-11-17     Completed Date:  2004-01-05     Revised Date:  2006-09-26    
Medline Journal Info:
Nlm Unique ID:  8712418     Medline TA:  Korean J Intern Med     Country:  Korea (South)    
Other Details:
Languages:  eng     Pagination:  196-8     Citation Subset:  IM    
Affiliation:
Department of Allergy and Rheumatology, Ajou University School of Medicine, San-5, Woncheon-dong, Paldal-gu, Suwon, 442-721, Korea.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Anti-Inflammatory Agents / therapeutic use
Dermatomyositis / drug therapy,  etiology*,  pathology
Female
Humans
Immunoglobulins, Intravenous / administration & dosage*
Prednisolone / therapeutic use
Pregnancy
Pregnancy Complications*
Pregnancy Trimester, First
Skin / pathology
Treatment Outcome
Chemical
Reg. No./Substance:
0/Anti-Inflammatory Agents; 0/Immunoglobulins, Intravenous; 50-24-8/Prednisolone

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Rapidly progressing Budd-Chiari syndrome complicated by hepatocellular carcinoma.
Next Document:  Disseminated cryptococcosis in a patient with pituitary Cushing's disease.